California State University - Interdisciplinary Cancer Meeting (CSU-ICM)
加州州立大学 - 跨学科癌症会议 (CSU-ICM)
基本信息
- 批准号:10539868
- 负责人:
- 金额:$ 0.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-01 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdvocateBasic ScienceBiological SciencesBiomedical ResearchCOVID-19CaliforniaCamellia sinensisCancer BiologyCancer ScienceCancer SurvivorClinicalCollaborationsCommunitiesDataDevelopmentDisciplineDoctor of PhilosophyEarly DiagnosisEnsureEventFacultyFeedbackFosteringFundingGeographyGrantInstitutesInstitutionInvestigationKnowledgeLeadLearningLifeMalignant NeoplasmsNeoplasm MetastasisOncologyParticipantPatientsPerformancePreparationResearchResearch PersonnelResistanceSchoolsScientific Advances and AccomplishmentsScientistSeminalSiteUnited States National Institutes of HealthUniversitiesVisceralWorkanticancer researchbasecancer typecareer networkingdemographicsdesigngraduate studentinnovationinsightinter-institutionalinterdisciplinary approachlectureslow socioeconomic statusmeetingsmortalitynovelpostersprogramsracial disparitysocioeconomicssuccesssymposiumtumortumor microenvironmentundergraduate studentunderrepresented minority studentvirtual
项目摘要
R13 Application
Kelber, Tamae, De Bellard
Title: The California State University – Interdisciplinary Cancer Meeting (CSU-ICM)
PROJECT SUMMARY
The average mortality across all cancer types remains at over 30%. To develop
transformative solutions to central problems in oncology research, we have established
the biennial California State University – Interdisciplinary Cancer Meeting (CSU-ICM).
This application is to support the 2022 meeting on The Tumor Microenvironment:
Challenges and Opportunities that will be held on Friday, October 21 at the California
State University Northridge, Plaza del Sol Performance Hall. This meeting addresses the
need for cancer research meetings that provide affordable and focused platforms for
interdisciplinary exchange between life scientists, non-life scientists and cancer experts.
The inaugural 2018 CSU-ICM welcomed Dr. Joan Brugge and over 150 participants. The
second CSU-ICM in 2020 was virtual due to COVID19 but was a big success and
welcomed Dr. Carlos Arteaga and over 70 participants. This application is based upon
preliminary data collected from the 2018 and 2020 events demonstrating diversity of
participation at ethnic, discipline, geographic and institute levels. We postulate that
strategic expansion of this meeting will stimulate novel, collaborative lines of investigation
that lead to transformative advances in cancer research and increase diversity in
oncology research. The short talk sessions will be chaired by faculty leaders and
designed around trainee presentations - increasing the upward mobility of those
traditionally underrepresented in cancer research. Involvement of cancer survivor-
advocates will underscore the need to ensure that even the most basic science research
is grounded in clear personal perspective. The world-renowned plenary speakers ensure
the highest quality of scientific exchange. The graduate school information session will
provide a tangible conduit for undergraduate and masters-level graduate students to gain
meaningful insights about program and application details from faculty representatives at
top-tier R1 institutions. Finally, the poster session is designed to foster scientific
exchange, networking opportunities and constructive feedback on work-in-progress. In
summary, the CSU-ICM is designed to advance scientific knowledge, learning, and
discovery; promotion of professional development; and preparation of a diverse scientific
workforce while also fulfilling an important need in the broader cancer research
community.
R13应用程序
凯尔伯,塔玛,德·贝拉德
标题:加利福尼亚州立大学 - 跨学科癌症会议(CSU-ICM)
项目摘要
所有癌症类型的平均死亡率均保持在30%以上。发展
解决肿瘤学研究中心问题的变革性解决方案,我们已经建立了
加利福尼亚州立大学双年展 - 跨学科癌症会议(CSU-ICM)。
该申请是为了支持2022年肿瘤微环境的会议:
将于10月21日星期五在加利福尼亚举行的挑战和机遇
州立大学Northridge,Plaza del Sol Performance Hall。这次会议介绍了
需要为癌症研究会议提供负担得起且集中的平台
生活科学家,非生活科学家和癌症专家之间的跨学科交流。
2018年首届CSU-ICM欢迎Joan Brugge博士和150多名参与者。这
2020年第二次CSU-ICM由于COVID19而虚拟,但取得了巨大的成功,
欢迎Carlos Arteaga博士和70多名参与者。此应用程序基于
2018年和2020年事件收集的初步数据证明了多样性
参加种族,纪律,地理和研究所级别。我们假设
这次会议的战略扩展将刺激新颖的协作调查线
这导致癌症研究的变革性进步并增加了多样性
肿瘤学研究。简短的谈话会议将由教师领导人主持
围绕学员演示设计 - 提高那些人的向上流动性
传统上,癌症研究中的人为不足。参与癌症幸存者
拥护者将强调需要确保即使是最基本的科学研究
以明确的个人观点为基础。世界知名的全体演讲者确保
科学交流的最高质量。研究生院信息会议将
为本科和硕士级别的研究生提供有形的管道
关于课程和申请详细信息的有意义的见解
顶级R1机构。最后,海报会议旨在培养科学
交换,网络机会和进行工作的建设性反馈。
总而言之,CSU-ICM旨在提高科学知识,学习和
发现;促进专业发展;并准备潜水员科学
劳动力同时还满足了更广泛的癌症研究的重要需求
社区。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jonathan Kelber其他文献
Jonathan Kelber的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jonathan Kelber', 18)}}的其他基金
Non-Transcriptional Mechanisms of PEAK1 Action During TGFbeta-Induced EMT
TGFbeta 诱导的 EMT 过程中 PEAK1 作用的非转录机制
- 批准号:
9208078 - 财政年份:2017
- 资助金额:
$ 0.5万 - 项目类别:
Spatiotemporal mechanisms of eIF5A1/2-mediated metastasis in triple-negative breast cancer
eIF5A1/2介导的三阴性乳腺癌转移的时空机制
- 批准号:
10546451 - 财政年份:2017
- 资助金额:
$ 0.5万 - 项目类别:
Spatiotemporal mechanisms of eIF5A1/2-mediated metastasis in triple-negative breast cancer
eIF5A1/2介导的三阴性乳腺癌转移的时空机制
- 批准号:
10724839 - 财政年份:2017
- 资助金额:
$ 0.5万 - 项目类别:
Spatiotemporal mechanisms of eIF5A1/2-mediated metastasis in triple-negative breast cancer
eIF5A1/2介导的三阴性乳腺癌转移的时空机制
- 批准号:
10545794 - 财政年份:2017
- 资助金额:
$ 0.5万 - 项目类别:
Spatiotemporal mechanisms of eIF5A1/2-mediated metastasis in triple-negative breast cancer
eIF5A1/2介导的三阴性乳腺癌转移的时空机制
- 批准号:
10613025 - 财政年份:2017
- 资助金额:
$ 0.5万 - 项目类别:
Spatiotemporal mechanisms of eIF5A1/2-mediated metastasis in triple-negative breast cancer
eIF5A1/2介导的三阴性乳腺癌转移的时空机制
- 批准号:
10088942 - 财政年份:2017
- 资助金额:
$ 0.5万 - 项目类别:
SPATIOTEMPORAL MECHANISMS OF EIF5A1/2-MEDIATED METASTASIS IN TRIPLE-NEGATIVE BREAST CANCER
EIF5A1/2介导的三阴性乳腺癌转移的时空机制
- 批准号:
10374539 - 财政年份:2017
- 资助金额:
$ 0.5万 - 项目类别:
Spatiotemporal mechanisms of eIF5A1/2-mediated metastasis in triple-negative breast cancer
eIF5A1/2介导的三阴性乳腺癌转移的时空机制
- 批准号:
10360453 - 财政年份:2017
- 资助金额:
$ 0.5万 - 项目类别:
相似海外基金
PUFA metabolism for prevention and treatment of TMD pain: an interdisciplinary, translational approach.
PUFA 代谢预防和治疗 TMD 疼痛:一种跨学科的转化方法。
- 批准号:
10820840 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别:
Facility Management, Maintenance and Operation Core
设施管理、维护和运营核心
- 批准号:
10793908 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别:
International Conference on Cancer Health Disparities
国际癌症健康差异会议
- 批准号:
10606212 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别:
The Cholangiocarcinoma Conference: Molecular Drivers, Microenvironment, and Precision Medicine
胆管癌会议:分子驱动因素、微环境和精准医学
- 批准号:
10747566 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别:
SAR 2023: From Mechanism to Patient-Centered Care: Research in Acupuncture and Traditional East Asian Medicine
SAR 2023:从机制到以患者为中心的护理:针灸和传统东亚医学研究
- 批准号:
10609124 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别: